ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2025
Bronchodilator Response in COPD: Definitions, Reference Equations, and Race.
Stephen T Russell, Vibha N Lama, Jordan A Kempker
Abstract read
In one paragraphArticle in Chronic obstructive pulmonary diseases (Miami, Fla.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
3 authors.
Stephen T RussellDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States.
Vibha N LamaDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States.
Jordan A KempkerDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States.
Funding
Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1MTranslational Dysregulation Driving Mesenchymal Cell Fibrogenic Transformation and Chronic Lung Allograft DysfunctionR01HL094622 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LAMA, VIBHA N · 2009 to 2023
$5.9MThe Emory Training Program in Lung HealthT32HL116271 · NHLBI · EMORY UNIVERSITY · PI BROWN, LOU ANN S, GUIDOT, DAVID MARSHALL · 2013 to 2022
$4.2MPathogenesis of Restrictive Allograft Syndrome Post-Lung TransplantationR01HL162171 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LAMA, VIBHA N · 2022 to 2025
$2.7MCystic Fibrosis Foundation 00003829Cystic Fibrosis Foundation 000075356Cystic Fibrosis Foundation 3829Cystic Fibrosis Foundation 75356National Heart, Lung, and Blood Institute T32 5T32HL116271National Institutes of Health-National Heart, Lung, and Blood Instistute-R01 HL094622National Institutes of Health-National Heart, Lung, and Blood Instistute-R01 HL162171NCATS NIH HHS UL1 TR002378NCATS NIH HHS UL1TR002378NHLBI NIH HHS R01 HL094622NHLBI NIH HHS R01 HL162171NHLBI NIH HHS T32 HL116271
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
bronchodilator responseCOPDreference equationsspirometry
Identifiers
PMID40774292
PMCPMC12614191
What OpenQuestion holds
Textmetadata
Read underepoch 390